Cover Image
QR Code

The Functional Medicine Approach to COVID-19: Primer on SARS-CoV-2 Testing.

The ability to accurately identify whether individuals are at risk for, infected with, or have an immune response to SARS-CoV-2 is essential to address the COVID-19 pandemic from both a personal, clinical and a public health perspective. We investigate the clinical value of testing for the presence...

Full description

Published in:Integrative Medicine: A Clinician's Journal Vol. 19; pp. 44 - 54
Main Authors: Messier, H., Evans, J. M., Hanaway, P. J.
Format: pictorial tables/charts Journal Article
Published: InnoVisions Professional Media 2020 Supplement1
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144250563&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 144250563
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1546993X
        1C2O
      jtl: Integrative Medicine: A Clinician's Journal
      issn: 1546993X
      maglogo: N
    pubinfo:
      dt: 2020 Supplement1
      vid: 19
      pid: 65582
      pub: InnoVisions Professional Media
      place: Eagan, Minnesota
    artinfo:
      ui:
        144250563
        144250563
        144250563
        144250563
      ppf: 44
      ppct: 10
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: The Functional Medicine Approach to COVID-19: Primer on SARS-CoV-2 Testing.
      aug:
        au:
          Messier, H.
          Evans, J. M.
          Hanaway, P. J.
        affil: Medical Intelligence Learning Lab, Inc (MILLI), San Jose, CA
      sug:
        subj:
          COVID-19 Diagnosis
          RNA
          Serologic Tests Methods
          Integrative Medicine
          Reverse Transcriptase Polymerase Chain Reaction
      ab: The ability to accurately identify whether individuals are at risk for, infected with, or have an immune response to SARS-CoV-2 is essential to address the COVID-19 pandemic from both a personal, clinical and a public health perspective. We investigate the clinical value of testing for the presence of viral RNA (a surrogate for infection) and the presence of antibodies (a proxy for immunity) to gather data to protect both individual and public health. We define the limitations and the practical clinical application of viral and serologic testing.
      pubtype: Academic Journal
      doctype:
        pictorial
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N